33 related articles for article (PubMed ID: 16955325)
1. "Good Publication Practice 2022 for Industry-Sponsored Research: An Update and Overview for Urology Authors".
DeTora L; Sant GR
Urology; 2023 Sep; 179():5-8. PubMed ID: 37353087
[No Abstract] [Full Text] [Related]
2. [Yesterday, today and tomorrow: urology and the pharmaceutical industry: successful team work for the benefit of the patient].
Cardinal A
Urologe A; 2006 Sep; 45 Suppl 4():43-4. PubMed ID: 16955326
[No Abstract] [Full Text] [Related]
3. [Clinical drug research in German urology from the viewpoint of a sponsor].
Burkart M
Urologe A; 2006 Sep; 45 Suppl 4():45-7. PubMed ID: 16832641
[No Abstract] [Full Text] [Related]
4. [The German Society of Urology in 2006. Well equipped for the challenges of the time].
Stöckle M
Urologe A; 2006 Sep; 45 Suppl 4():8-11. PubMed ID: 16902790
[No Abstract] [Full Text] [Related]
5. [Changes in urology - appeal by the presidents of the German Society of Urology and Association of German Urologists: fair cooperation instead of more competition].
Schroeder A; Steffens J
Urologe A; 2011 Aug; 50(8):911-3. PubMed ID: 21811931
[No Abstract] [Full Text] [Related]
6. [The common future of urology and the pharmaceutical industry].
Odenthal G
Urologe A; 2006 Sep; 45 Suppl 4():41-3. PubMed ID: 16955325
[No Abstract] [Full Text] [Related]
7. [Securing the future of urology. Our lesson for the coming years].
Steffens JA
Urologe A; 2011 Sep; 50(9):1040-6. PubMed ID: 21842195
[TBL] [Abstract][Full Text] [Related]
8. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
Vallance P; Williams P; Dollery C
Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
[No Abstract] [Full Text] [Related]
9. [Both major breakthroughs and stagnation in urology. Industry, together with clinicians, are responsible for most innovations].
Hedelin H; Grenabo L; Holmäng S
Lakartidningen; 2001 May; 98(20):2440-4. PubMed ID: 11433974
[TBL] [Abstract][Full Text] [Related]
10. [Andrology--historical retrospect and future development].
Schill WB
Fortschr Med; 1994 Dec; 112(34):496-9. PubMed ID: 7843676
[TBL] [Abstract][Full Text] [Related]
11. [Developments by pharmaceutical companies].
Orthel FW
Tijdschr Diergeneeskd; 2001 Feb; 126(3):76-84. PubMed ID: 11227404
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
